Predictors of Failed Thrombolysis in Acute Myocardial Infarction

Recruiting Observational Study
STEMI - ST Elevation Myocardial Infarction
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Oslo University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this observational study is to assess why thrombolytic treatment with tissue-plasminogen activator (t-PA) fails in patients with acute ST-segment elevation myocardial infarction (STEMI). The study will include 200 STEMI patients at the time of arrival at Oslo University Hospital Ullevål after receiving prehospital thrombolysis. A blood sample will be taken immediately for the study …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: STEMI patients \> 18 years given prehospital thrombolysis. Exclusion Criteria: None.
Contacts

Ragnhild Helseth, MD PhD

+47 97 14 95 18

ramhel@ous-hf.no

CONTACT

Kristine Kindberg, MD

+4748255362

kromoe@ous-hf.no

CONTACT